Cash Cash Equivalents - Bausch Health Companies Inc (NYSE:BHC) - Alpha Spread
B

Bausch Health Companies Inc
NYSE:BHC

Watchlist Manager
Bausch Health Companies Inc
NYSE:BHC
Watchlist
Price: 8.32 USD 0.6% Market Closed
Market Cap: 3.1B USD
Have any thoughts about
Bausch Health Companies Inc?
Write Note

Bausch Health Companies Inc
Cash & Cash Equivalents

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Bausch Health Companies Inc
Cash & Cash Equivalents Peer Comparison

Comparables:
SNDL
C
CRON
C
CURA
T
TER

Competitive Cash & Cash Equivalents Analysis
Latest Figures & CAGR of Competitors

Company Cash & Cash Equivalents CAGR 3Y CAGR 5Y CAGR 10Y
B
Bausch Health Companies Inc
NYSE:BHC
Cash & Cash Equivalents
$595m
CAGR 3-Years
-3%
CAGR 5-Years
-7%
CAGR 10-Years
1%
Sundial Growers Inc
NASDAQ:SNDL
Cash & Cash Equivalents
CA$195m
CAGR 3-Years
48%
CAGR 5-Years
69%
CAGR 10-Years
N/A
C
Cronos Group Inc
NASDAQ:CRON
Cash & Cash Equivalents
$848.2m
CAGR 3-Years
-2%
CAGR 5-Years
-7%
CAGR 10-Years
N/A
C
Curaleaf Holdings Inc
CNSX:CURA
Cash & Cash Equivalents
$118.1m
CAGR 3-Years
12%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
T
Terrascend Corp
CNSX:TER
Cash & Cash Equivalents
$26.2m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Bausch Health Companies Inc's Cash & Cash Equivalents?
Cash & Cash Equivalents
595m USD

Based on the financial report for Jun 30, 2024, Bausch Health Companies Inc's Cash & Cash Equivalents amounts to 595m USD.

What is Bausch Health Companies Inc's Cash & Cash Equivalents growth rate?
Cash & Cash Equivalents CAGR 10Y
1%

Over the last year, the Cash & Cash Equivalents growth was 3%. The average annual Cash & Cash Equivalents growth rates for Bausch Health Companies Inc have been -3% over the past three years , -7% over the past five years , and 1% over the past ten years .

Back to Top